Ahlcon Parenterals (India) Ltd.

Name: Ahlcon Parenterals (India) Ltd. Share Price Today, Stock Analysis
Brand: Ahlcon Parenterals (India) Ltd.

Stock Card

BSE: 524448

₹515.00

₹-1.00 (-0.19%)

As on 21-Jan-2015IST

Market cap

₹371 Cr

Revenue (TTM)

₹176 Cr

P/E Ratio

P/B Ratio

4.3

Div. Yield

0 %

Ahlcon Parenterals (India) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 514.75 High: 516.75

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹-20 Cr
ROE

0 %
ROCE

2.7 %
Industry P/E

37.74
EV/EBITDA

117.3
Debt to Equity

-2.9
Book Value

₹-161
EPS

₹-27.5
Face value

10
Shares outstanding

7,200,150

10 Years Aggregate

CFO

₹214.77 Cr

EBITDA

₹205.99 Cr

Net Profit

₹-156.36 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ahlcon Parenterals (India)	0.2	0.6	-10.0	13.4	62.6	60.3	39.4
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
BSE Healthcare^#	18.8	2.8	8.7	17.1	23.1	14.8	12.4

As on 21-Jan-2015 | *As on 28-Aug-2026 | #As on 28-Aug-2026

Company	2014
Ahlcon Parenterals (India)	10.9
BSE Sensex	29.9
BSE Healthcare	47.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Ahlcon Parenterals (India)	515.0	370.8	175.7	-19.8	22.1	0	--	4.3
Acutaas Chemicals	3,281.6	26,870.9	1,461.8	387.4	34.5	25.2	69.6	15.5
Alembic Pharma	813.5	16,000.2	7,784.0	688.5	10.6	14	23.1	2.7
Cohance Lifesciences	449.9	17,241.8	2,141.5	58.5	5.8	3.3	162.3	4.5
Granules India	836.7	20,739.4	5,632.3	662.4	17.2	14.3	31.3	4.2
Onesource Specialty Pharma	1,532.2	17,579.4	1,543.3	-48.6	3.6	-0.6	--	3.0
Piramal Pharma	218.7	29,103.3	9,205.3	-371.8	1.7	-3.8	--	3.6
Rubicon Research	1,804.4	29,891.8	1,935.8	288.2	20.6	29.8	103.7	22.3
Syngene Intl	403.4	16,284.0	3,600.2	221.0	9.7	5.6	73.7	3.4
Wockhardt	1,977.1	32,103.6	3,564.0	414.0	15.3	8.4	78.5	6.4

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Ahlcon Parenterals (India)

Incorporated

1992
Chairman

Andreas Walde
Managing Director

Indranil Mukherjee
Group

Ahlcon Parenterals - MNC
Headquarters

New Delhi, Delhi
Website

www.ahlconindia.com

FAQs for Ahlcon Parenterals (India)

What is the current share price of Ahlcon Parenterals (India) Ltd Today?

The share price of Ahlcon Parenterals (India) Ltd is ₹515.00 (BSE) as of 21-Jan-2015 IST. Ahlcon Parenterals (India) Ltd has given a return of 62.61% in the last 3 years.

What is the current PB & PE ratio of Ahlcon Parenterals (India) Ltd?

Since, TTM earnings of Ahlcon Parenterals (India) Ltd is negative, P/E ratio is not available.
The P/B ratio of Ahlcon Parenterals (India) Ltd is 4.31 times as on 21-Jan-2015, a 34 premium to its peers’ median range of 3.22 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	0.00	0.00
2021	0.00	0.00
2020	0.00	0.00
2019	0.00	0.00
2018	0.00	0.00

What is the 52 Week High and Low of Ahlcon Parenterals (India) Ltd?

The 52-week high and low of Ahlcon Parenterals (India) Ltd are Rs -- and Rs -- as of 29-Aug-2026.

What is the market cap of Ahlcon Parenterals (India) Ltd?

Ahlcon Parenterals (India) Ltd has a market capitalisation of ₹ 371 Cr as on 21-Jan-2015. As per SEBI classification, it is a company.

Should I invest in Ahlcon Parenterals (India) Ltd?

Before investing in Ahlcon Parenterals (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.